Fotemustine in recurrent or progressive glioblastoma multiforme (GBM)

被引：0
|
作者：
Savio, G. [1 ]
Pepe, A. [1 ]
Laudani, A. [1 ]
Leonardi, V [1 ]
Usset, A. [1 ]
Rondello, G. [1 ]
Arcuri, C. [1 ]
Palmisano, V [1 ]
Alu', M. [1 ]
Macaluso, M. [1 ]
Agostara, B. [1 ]
机构：
[1] ARNAS Civic, Oncol Hosp, Dept Oncol, Palermo, Italy
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [21] Phase I/II study of dianhydrogalactitol in patients with recurrent malignant glioblastoma multiforme (GBM).
    Shih, Kent C.
    Patel, Manish R.
    Butowski, Nicholas A.
    Bacha, Jeffrey A.
    Brown, Dennis
    Garner, William J.
    Stelno, Anne
    Schwartz, Richard Stephen
    Kanekal, Sarath
    Lopez, Lorena
    Burris, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] Phase I study of gefitinib and rapamycin in adult patients with recurrent glioblastoma multiforme (GBM).
    Phuphanich, Surasak
    Chu, Ray
    Yu, John S.
    Black, Keith L.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3462S - 3462S
  • [23] Treatment of recurrent anaplastic astrocytoma (AA) and glioblastoma multiforme (GBM) with the glutamate antagonist riluzole
    Das, A
    Learn, J
    Le, MT
    Yu, J
    Pikul, B
    Black, K
    NEURO-ONCOLOGY, 2004, 6 (04) : 373 - 373
  • [24] EFFICACY AND TOLERABILITY OF BEVACIZUMAB MONOTHERAPY IN PATIENTS WITH PREVIOUSLY TREATED RECURRENT GLIOBLASTOMA MULTIFORME (GBM)
    Francini, E.
    Mazzaroppi, S.
    Salvati, M.
    Caponnetto, S.
    Laera, L.
    Migali, C.
    Bianco, V.
    NEURO-ONCOLOGY, 2014, 16
  • [25] NCCTG phase II trial of CCI-779 in recurrent glioblastoma multiforme (GBM).
    Galanis, E
    Buckner, JC
    Maurer, M
    Ballman, K
    Hidalgo, M
    Kreisberg, JI
    Boni, J
    James, CDD
    Jenkins, RB
    Walsh, DJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 107S - 107S
  • [26] PHASE I/II STUDY OF DIANHYDROGALACTITOL IN PATIENTS WITH RECURRENT MALIGNANT GLIOBLASTOMA MULTIFORME (GBM)
    Shih, Kent
    Patel, Manish
    Butowski, Nicholas
    Bacha, Jeffrey
    Brown, Dennis
    Garner, William
    Steino, Anne
    Schwartz, Richard
    Kanekal, Sarath
    Lopez, Lorena
    Burris, Howard A., III
    NEURO-ONCOLOGY, 2014, 16
  • [27] Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme
    Larson, DA
    Suplica, JM
    Chang, SM
    Lamborn, KR
    McDermott, MW
    Sneed, PK
    Prados, MD
    Wara, WM
    Nicholas, MK
    Berger, MS
    NEURO-ONCOLOGY, 2004, 6 (02) : 119 - 126
  • [28] Second-line chemotherapy with dacarbazine and fotemustine in nitrosourea-pretreated patients with recurrent glioblastoma multiforme
    Fazeny-Dörner, B
    Veitl, M
    Wenzel, C
    Piribauer, M
    Rössler, K
    Dieckmann, K
    Ungersböck, K
    Marosi, C
    ANTI-CANCER DRUGS, 2003, 14 (06) : 437 - 442
  • [29] Using Light for Therapy of Glioblastoma Multiforme (GBM)
    Vasilev, Alex
    Sofi, Roba
    Rahman, Ruman
    Smith, Stuart J.
    Teschemacher, Anja G.
    Kasparov, Sergey
    BRAIN SCIENCES, 2020, 10 (02)
  • [30] Overexpression of osteopontin (OPN) in glioblastoma multiforme (GBM).
    Haddix, TL
    Recht, LD
    Myles, T
    Leung, LLK
    Vogel, H
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2005, 64 (05): : 456 - 456
12345